|
PCBD2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.20780000000209E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.73230000000335E-05 |
| Normal-vs-Stage2 |
1.095040E-01 |
| Normal-vs-Stage3 |
9.273900E-02 |
| Normal-vs-Stage4 |
2.294800E-01 |
| Stage1-vs-Stage2 |
4.644600E-01 |
| Stage1-vs-Stage3 |
6.040400E-01 |
| Stage1-vs-Stage4 |
7.440600E-01 |
| Stage2-vs-Stage3 |
9.254400E-01 |
| Stage2-vs-Stage4 |
8.748000E-01 |
| Stage3-vs-Stage4 |
9.411400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.74920000000278E-05 |
| Normal-vs-AfricanAmerican |
3.738300E-02 |
| Normal-vs-Asian |
8.707600E-02 |
| Caucasian-vs-AfricanAmerican |
2.325000E-01 |
| Caucasian-vs-Asian |
3.820400E-01 |
| AfricanAmerican-vs-Asian |
2.665200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.358040E-04 |
| Normal-vs-Female |
8.997500E-04 |
| Male-vs-Female |
7.463600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.295750E-03 |
| Normal-vs-Extreme_Weight |
2.244800E-04 |
| Normal-vs-Obese |
9.822600E-03 |
| Normal-vs-Extreme_Obese |
3.218800E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.340200E-01 |
| Normal_Weight-vs-Obese |
5.936800E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.902000E-01 |
| Extreme_Weight-vs-Obese |
5.788000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.023800E-01 |
| Obese-vs-Extreme_Obese |
7.611600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.963000E-03 |
| Normal-vs-Age(41-60Yrs) |
6.543500E-03 |
| Normal-vs-Age(61-80Yrs) |
2.462999999997E-05 |
| Normal-vs-Age(81-100Yrs) |
1.224980E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.758400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.507000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.113390E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.369180E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.265600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.564200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.50389999997724E-06 |
| Normal-VS-Type2 PRCC |
6.806200E-01 |
| Normal-VS-KIRP CIMP |
1.17359455487076E-11 |
| Normal-VS-Unclassified PRCC |
4.973700E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.580300E-04 |
| Type1 PRCC-VS-KIRP CIMP |
3.62139999998679E-06 |
| Type1 PRCC-VS-Unclassified PRCC |
1.945190E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.01399996679896E-09 |
| Type2 PRCC-VS-Unclassified PRCC |
1.306790E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.88739999968024E-07 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.356400E-03 |
| Normal-vs-N1 |
9.840400E-02 |
| Normal-vs-N2 |
2.037800E-04 |
| N0-vs-N1 |
9.256400E-01 |
| N0-vs-N2 |
2.133000E-01 |
| N1-vs-N2 |
3.646000E-01 |
|
|
